With the threat of pharmaceutical tariffs hanging over the biopharmaceutical industry, Roche is the latest addition to a growing list of major drugmakers that are bolstering their manufacturing footprints in the U.S.
Roche to Swell US Footprint with $50B Investment
Comment
Show comments
Hide Comments
